Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions
Authors:
- 1 September 2015
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 28 (1) , 626-633
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81273526, 81302783)
- Anhui University of Science and Technology (ZRC2014473)
This publication has 97 references indexed in Scilit:
- The HIV-1 Nef Protein Binds Argonaute-2 and Functions as a Viral Suppressor of RNA InterferencePLOS ONE, 2013
- Fibrosis in systemic sclerosis: common and unique pathobiologyFibrogenesis & Tissue Repair, 2012
- The Crystal Structure of Human Argonaute2Science, 2012
- Mutations in the GW-repeat protein SUO reveal a developmental function for microRNA-mediated translational repression in ArabidopsisProceedings of the National Academy of Sciences, 2011
- Pulmonary arterial hypertension associated with systemic sclerosisExpert Review of Respiratory Medicine, 2011
- MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseasesTranslational Research, 2011
- The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritisArthritis & Rheumatism, 2011
- Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosisAmerican Journal of Physiology-Cell Physiology, 2011
- Analysis of microRNA knockouts in miceHuman Molecular Genetics, 2010
- Unintentional miRNA Ablation Is a Risk Factor in Gene Knockout Studies: A Short ReportPLOS Genetics, 2008